SHF (SHFS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Net income reached $0.94 million in Q2 2024, reversing a $17.6 million net loss in Q2 2023, with positive gross profit and sharply reduced operating expenses.
Revenue for Q2 2024 was $4.0 million, down 12% year-over-year, mainly due to reduced deposit activity and onboarding income.
Loan interest income surged 204% year-over-year to $1.8 million in Q2 2024, driven by lending platform expansion and new credit programs.
Cash and cash equivalents as of June 30, 2024, were $6.1 million, up from $4.9 million at year-end 2023.
The company operates a proprietary platform for deposit compliance, onboarding, and loan servicing, focusing on cannabis-related businesses in 41 states.
Financial highlights
Six-month revenue was $8.1 million, down 7.6% year-over-year.
Six-month net income was $3.0 million, compared to a $19.0 million net loss in the prior year period.
Adjusted EBITDA for Q2 2024 was $0.97 million, up from $0.85 million in Q2 2023; six-month Adjusted EBITDA was $2.06 million, up from $1.26 million in 2023.
Operating expenses for Q2 2024 were $3.7 million, down from $22.5 million in Q2 2023.
Total assets as of June 30, 2024, were $67.3 million; total liabilities were $28.9 million; equity was $38.5 million.
Outlook and guidance
Full-year 2024 revenue expected in the range of $17–$18 million.
Full-year 2024 Adjusted EBITDA projected between $3.75–$4.25 million.
Management expects a shift in account and fee trends as the lending program expands, with a focus on higher-margin products and regulatory changes favoring the cannabis sector.
Latest events from SHF
- Registers 21.5M shares for resale; proceeds from warrant exercises may support working capital.SHFS
Registration filing16 Jul 2026 - Director elections and auditor ratification were approved, with results to be filed with the SEC.SHFS
AGM 202617 Jun 2026 - Registering 22.6M shares for resale, company faces losses, liquidity, and compliance risks.SHFS
Registration filing4 Jun 2026 - Board expanded with new directors to strengthen governance and industry expertise.SHFS
Proxy filing28 May 2026 - Net loss widened to $1.8M as loan program income surged and liquidity concerns persisted.SHFS
Q1 202618 May 2026 - Tyler Klimas is confirmed as chairman of the Nominating and Corporate Governance Committee.SHFS
Proxy filing11 May 2026 - Annual meeting to elect directors and ratify auditor, with major governance and compensation updates.SHFS
Proxy filing8 May 2026 - Election of two directors and auditor ratification are up for vote at the June 2026 annual meeting.SHFS
Proxy filing8 May 2026 - IPO filing: cannabis fintech with declining revenue, high partner concentration, and new loan indemnification risk.SHFS
Registration filing6 May 2026